Literature DB >> 1826403

The clinical manifestation of mental disorder in Huntington's disease: a retrospective case record study of disease progression.

S Pflanz1, J A Besson, K P Ebmeier, S Simpson.   

Abstract

All cases (86) of Huntington's Disease presenting between 1970 and 1987 in the Grampian Health Board region were identified and a case note analysis of neurological and psychiatric syndromes carried out--the latter using the PSE syndrome check-list. The commonest syndromes were organic impairment, irritability, loss of interest and concentration and simple depression and these were often the presenting psychiatric syndromes. General anxiety, worrying and social unease occurred early, commonly before movement disorder and were associated with longer survival.

Entities:  

Mesh:

Year:  1991        PMID: 1826403     DOI: 10.1111/j.1600-0447.1991.tb05511.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  19 in total

1.  Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.

Authors:  Noelle E Carlozzi; Siera Goodnight; Anna L Kratz; Julie C Stout; Michael K McCormack; Jane S Paulsen; Nicholas R Boileau; David Cella; Rebecca E Ready
Journal:  J Huntingtons Dis       Date:  2019

2.  Anticipation or ascertainment bias in schizophrenia? Penrose's familial mental illness sample.

Authors:  A S Bassett; J Husted
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

Review 3.  Anticipation and CAG*CTG repeat expansion in schizophrenia and bipolar affective disorder.

Authors:  M Teresa Fortune; James L Kennedy; John B Vincent
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

4.  Familial psychiatric presentation of Huntington's disease.

Authors:  S Lovestone; S Hodgson; P Sham; A M Differ; R Levy
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

5.  Psychiatric disorders in preclinical Huntington's disease.

Authors:  Camille L Julien; Jennifer C Thompson; Sue Wild; Pamela Yardumian; Julie S Snowden; Gwen Turner; David Craufurd
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-18       Impact factor: 10.154

Review 6.  Choosing an animal model for the study of Huntington's disease.

Authors:  Mahmoud A Pouladi; A Jennifer Morton; Michael R Hayden
Journal:  Nat Rev Neurosci       Date:  2013-10       Impact factor: 34.870

7.  Patterns of serotonergic antidepressant usage in prodromal Huntington disease.

Authors:  Kelly C Rowe; Jane S Paulsen; Douglas R Langbehn; Chiachi Wang; James Mills; Leigh J Beglinger; Megan M Smith; Eric A Epping; Jess G Fiedorowicz; Kevin Duff; Adam Ruggle; David J Moser
Journal:  Psychiatry Res       Date:  2012-03-05       Impact factor: 3.222

Review 8.  An overview of psychiatric symptoms in Huntington's disease.

Authors:  K E Anderson; K S Marder
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 9.  Functional consequences of HIV-associated neuropsychological impairment.

Authors:  Ashley A Gorman; Jessica M Foley; Mark L Ettenhofer; Charles H Hinkin; Wilfred G van Gorp
Journal:  Neuropsychol Rev       Date:  2009-05-27       Impact factor: 7.444

10.  Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease.

Authors:  Brett D Dufour; Jodi L McBride
Journal:  Exp Neurol       Date:  2016-07-02       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.